You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Radiation Treatment

The guidelines and other documents available here provide recommendations related to radiation treatment for people with cancer in Ontario.

Radiation Treatment Quality-Based Procedures

Displaying Guidelines

63 Items

Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Document Status: Archived
ID: 5-6c

Nov 2000

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

Document Status: Archived
ID: 4-10

Aug 2013

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

Document Status: Archived
ID: 3-17
Version: 3

May 2014

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Document Status: Archived
ID: GL-7-A-2016-3

Apr 2017

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Mar 2024

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Nov 2024

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Document Status: Current
ID: GL END 7-24

Nov 2024

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Document Status: Current

Oct 2019

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Document Status: Current

Apr 2020